{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:46:24Z","timestamp":1794674784964,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82472029"],"award-info":[{"award-number":["No. 82472029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81901662"],"award-info":[{"award-number":["No.81901662"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81901784"],"award-info":[{"award-number":["No.81901784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Central South University school-enterprise joint new project","award":["NO.2024XQLH112"],"award-info":[{"award-number":["NO.2024XQLH112"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00259-025-07523-5","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T02:11:22Z","timestamp":1755655882000},"page":"1270-1278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["[18F]F-FAPI PET\/CT outperforms [18F]F-FDG PET\/CT in predicting treatment response in lupus nephritis"],"prefix":"10.1007","volume":"53","author":[{"given":"Min","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1211-8431","authenticated-orcid":false,"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"7523_CR1","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110\u201321. https:\/\/doi.org\/10.1056\/NEJMra1100359.","journal-title":"N Engl J Med"},{"key":"7523_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/acr.21664","volume":"64","author":"BH Hahn","year":"2012","unstructured":"Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American college of rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012;64:797\u2013808. https:\/\/doi.org\/10.1002\/acr.21664.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7523_CR3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/art.10558","volume":"47","author":"AF Kavanaugh","year":"2002","unstructured":"Kavanaugh AF, Solomon DH, American College of Rheumatology Ad Hoc Committee on Immunologic Testing G. Guidelines for Immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum. 2002;47:546\u201355. https:\/\/doi.org\/10.1002\/art.10558.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 10","key":"7523_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/acr.24221","volume":"72","author":"S Arora","year":"2020","unstructured":"Arora S, Isenberg DA, Castrejon I. Measures of adult systemic lupus erythematosus: disease activity and damage. Arthritis Care Res (Hoboken). 2020;72(Suppl 10):27\u201346. https:\/\/doi.org\/10.1002\/acr.24221.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7523_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/OARRR.S112829","volume":"8","author":"SC Hsieh","year":"2016","unstructured":"Hsieh SC, Tsai CY, Yu CL. Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems. Open Access Rheumatol. 2016;8:81\u201391. https:\/\/doi.org\/10.2147\/OARRR.S112829.","journal-title":"Open Access Rheumatol"},{"key":"7523_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nrrheum.2015.69","volume":"11","author":"OP Rekvig","year":"2015","unstructured":"Rekvig OP. The anti-DNA antibody: origin and impact, dogmas and controversies. Nat Rev Rheumatol. 2015;11:530\u201340. https:\/\/doi.org\/10.1038\/nrrheum.2015.69.","journal-title":"Nat Rev Rheumatol"},{"key":"7523_CR7","doi-asserted-by":"publisher","first-page":"e7099","DOI":"10.1097\/md.0000000000007099","volume":"96","author":"J Narv\u00e1ez","year":"2017","unstructured":"Narv\u00e1ez J, Ricse M, Gom\u00e0 M, Mitjavila F, Fulladosa X, Capdevila O, et al. The value of repeat biopsy in lupus nephritis flares. Med (Baltim). 2017;96:e7099. https:\/\/doi.org\/10.1097\/md.0000000000007099.","journal-title":"Med (Baltim)"},{"key":"7523_CR8","doi-asserted-by":"publisher","first-page":"sfae350","DOI":"10.1093\/ckj\/sfae350","volume":"17","author":"J Hou","year":"2024","unstructured":"Hou J, Liang D, Quan S, Liu Z, Liu Z. Predictive value of residual active histologic lesions on renal flare in lupus nephritis patients with clinical remission. Clin Kidney J. 2024;17:sfae350. https:\/\/doi.org\/10.1093\/ckj\/sfae350.","journal-title":"Clin Kidney J"},{"key":"7523_CR9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","volume":"105","author":"Kidney Disease","year":"2024","unstructured":"Kidney Disease. Improving global outcomes lupus nephritis work G. KDIGO 2024 clinical practice guideline for the management of LUPUS NEPHRITIS. Kidney Int. 2024;105:S1\u201369. https:\/\/doi.org\/10.1016\/j.kint.2023.09.002.","journal-title":"Kidney Int"},{"key":"7523_CR10","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/art.10461","volume":"46","author":"FA Houssiau","year":"2002","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus nephritis trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum. 2002;46:2121\u201331. https:\/\/doi.org\/10.1002\/art.10461.","journal-title":"Arthritis Rheum"},{"key":"7523_CR11","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1056\/NEJMoa1014460","volume":"365","author":"MA Dooley","year":"2011","unstructured":"Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, et al. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med. 2011;365:1886\u201395. https:\/\/doi.org\/10.1056\/NEJMoa1014460.","journal-title":"N Engl J Med"},{"key":"7523_CR12","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1136\/ard.2010.131995","volume":"69","author":"FA Houssiau","year":"2010","unstructured":"Houssiau FA, D\u2019Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, et al. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN nephritis trial. Ann Rheum Dis. 2010;69:2083\u20139. https:\/\/doi.org\/10.1136\/ard.2010.131995.","journal-title":"Ann Rheum Dis"},{"key":"7523_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","volume":"55","author":"JG Hanly","year":"2016","unstructured":"Hanly JG, O\u2019Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford). 2016;55:252\u201362. https:\/\/doi.org\/10.1093\/rheumatology\/kev311.","journal-title":"Rheumatology (Oxford)"},{"key":"7523_CR14","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2967\/jnumed.124.268643","volume":"66","author":"S Yu","year":"2025","unstructured":"Yu S, Yang Z, Ding Z, Jia Y, Wan L, Li L, et al. (68)Ga-FAPI-04 PET\/CT imaging for assessing renal tubulointerstitial fibrosis in lupus nephritis. J Nucl Med. 2025;66:418\u201324. https:\/\/doi.org\/10.2967\/jnumed.124.268643.","journal-title":"J Nucl Med"},{"key":"7523_CR15","doi-asserted-by":"publisher","first-page":"e42522","DOI":"10.1016\/j.heliyon.2025.e42522","volume":"11","author":"H Jiao","year":"2025","unstructured":"Jiao H, Qiu Y, Chen Z, Zhang Y, Huang W, Yang Q, et al. Multiple metabolic analysis of [(18)F]FDG PET\/CT in patients with kidney disease. Heliyon. 2025;11:e42522. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42522.","journal-title":"Heliyon"},{"key":"7523_CR16","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78:736\u201345. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215089.","journal-title":"Ann Rheum Dis"},{"key":"7523_CR17","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1007\/s00259-021-05470-5","volume":"48","author":"S Wang","year":"2021","unstructured":"Wang S, Zhou X, Xu X, Ding J, Liu S, Hou X, et al. Clinical translational evaluation of Al(18)F-NOTA-FAPI for fibroblast activation protein-targeted tumour imaging. Eur J Nucl Med Mol Imaging. 2021;48:4259\u201371. https:\/\/doi.org\/10.1007\/s00259-021-05470-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7523_CR18","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1007\/s00259-021-05660-1","volume":"49","author":"P Conen","year":"2022","unstructured":"Conen P, Pennetta F, Dendl K, Hertel F, Vogg A, Haberkorn U, et al. [(68) Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease. Eur J Nucl Med Mol Imaging. 2022;49:3365\u201372. https:\/\/doi.org\/10.1007\/s00259-021-05660-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7523_CR19","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1046\/j.1523-1755.2002.00357.x","volume":"61","author":"GS Hill","year":"2002","unstructured":"Hill GS, Delahousse M, Nochy D, Thervet E, Vrtovsnik F, Remy P, et al. Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy. Kidney Int. 2002;61:2176\u201386. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00357.x.","journal-title":"Kidney Int"},{"key":"7523_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/acr.20441","volume":"63","author":"C Hsieh","year":"2011","unstructured":"Hsieh C, Chang A, Brandt D, Guttikonda R, Utset TO, Clark MR. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res (Hoboken). 2011;63:865\u201374. https:\/\/doi.org\/10.1002\/acr.20441.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7523_CR21","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/ndt\/gft201","volume":"28","author":"SM Korbet","year":"2013","unstructured":"Korbet SM, Lewis EJ, Collaborative Study G. Severe lupus nephritis: the predictive value of a >\/= 50% reduction in proteinuria at 6 months. Nephrol Dial Transpl. 2013;28:2313\u20138. https:\/\/doi.org\/10.1093\/ndt\/gft201.","journal-title":"Nephrol Dial Transpl"},{"key":"7523_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4078\/jrd.22.0006","volume":"29","author":"DJ Park","year":"2022","unstructured":"Park DJ, Joo YB, Bang SY, Lee J, Lee HS, Bae SC. Predictive factors for renal response in lupus nephritis: A Single-center prospective cohort study. J Rheum Dis. 2022;29:223\u201331. https:\/\/doi.org\/10.4078\/jrd.22.0006.","journal-title":"J Rheum Dis"},{"key":"7523_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11307-023-01820-x","volume":"25","author":"X Chi","year":"2023","unstructured":"Chi X, Yang X, Li G, Wu H, Huang J, Qi Y, et al. A comparative study of 18F-FAPI-42 and 18F-FDG PET\/CT for evaluating acute kidney injury in cancer patients. Mol Imaging Biology. 2023;25:671\u201380. https:\/\/doi.org\/10.1007\/s11307-023-01820-x.","journal-title":"Mol Imaging Biology"},{"key":"7523_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.12688\/f1000research.6587.2","volume":"4","author":"JM Thurman","year":"2015","unstructured":"Thurman JM, Serkova NJ. Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus. F1000Res. 2015;4:153. https:\/\/doi.org\/10.12688\/f1000research.6587.2.","journal-title":"F1000Res"},{"key":"7523_CR25","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1097\/RLU.0000000000005598","volume":"50","author":"W Zhang","year":"2025","unstructured":"Zhang W, Qi Z, Shen G. Lupus nephritis revealed by FAPI PET\/CT. Clin Nucl Med. 2025;50:e171\u20132. https:\/\/doi.org\/10.1097\/RLU.0000000000005598.","journal-title":"Clin Nucl Med"},{"key":"7523_CR26","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1097\/RLU.0000000000005598","volume":"50","author":"W Zhang","year":"2025","unstructured":"Zhang W, Qi Z, Shen G. Lupus nephritis revealed by FAPI PET\/CT. Clin Nucl Med. 2025;50:e171-2. https:\/\/doi.org\/10.1097\/RLU.0000000000005598.","journal-title":"Clin Nucl Med."}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07523-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07523-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07523-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:46:22Z","timestamp":1769222782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07523-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7523"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07523-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) of the Third Xiangya Hospital, Central South University (No.FR25317), and written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}